This deliverable investigates sustainability gains and trade-offs of AeroSolfd solutions when deployed at scale, suggesting implications for stakeholders.
This deliverable investivates whether the three AeroSolfd retrofit solutions deliver net sustainability gains across their full life cycles, what trade-offs arise, and who benefits from them when deployed in scale.
No takes yet. Share an insight, caveat, or question.
Liguori et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: